Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Distigmine (Atc Code According To Who: N07Aa03)

AOK PLUS - Die Gesundheitskasse fur Sachsen und Thuringen Germany has Released a tender for Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Distigmine (Atc Code According To Who: N07Aa03) in Pharmaceuticals. The tender was released on Aug 16, 2024.

Country - Germany

Summary - Conclusion Of A Non-Exclusive Drug Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V By Means Of An Open House Model For The Active Ingredient Distigmine (Atc Code According To Who: N07Aa03)

Deadline - Oct 31, 2026

MT reference number - 90980416

Product classification - Pharmaceutical products

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 90980416

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Scope of procurementBrief descriptionThe subject of this publication is the conclusion of non-exclusive discount agreements in accordance with Section 130a Paragraph 8 of the Social Code Book V for medicinal products containing the activ e ingredient distigmine (ATC code according to WHO: N07AA03).The contract is concluded within the framework of a so-called open house model, i.e. a contract is open to all interested pharmaceutical companies within the participation period, provided they meet and accept the participation requirements. This means that individual contract negotiations are not conducted and there is no (supply) exclusivity. It should be noted that the purchase quant

Mt Ref Id - 90980416

Deadline - Oct 31, 2026

Share

Similar Tenders :